REFERENCES
- Liebenschutz, F., Mai, C., Pickerodt, V.W.A.: Increased carbon dioxide production in two patients with malignant hyperpyrexia and its control by dantrolene. Br. J. Anaesth. 51: 899–903, 1979.
- Lips, F.J., Newland, M., Dutton, G.: Malignant hyperthermia triggered by cyclopropane during Caesarian Section. Anaesthesiology 56: 144–146, 1982.
- Wadhwa, R.K.: Obstetric anaesthesia for a patient with malignant hyperthermia susceptibility. Anaesthesiology 46: 63–64, 1977.
- Willatts, S.M.: Malignant hyperthermia susceptibility. Management during pregnancy and labour. Anaesthesia 34: 41–46, 1979.
- Ferris, J.A.J., Friesen, J.M.: Definitions of ischemia, infarction and necrosis. Forensic Science International 13: 253–258, 1979.
- Huckell, V.F., Staniloff, H.M., Britt, B.A., Waxman, M.B., Morch, J.E. Cardiac manifestations of malignant hyperthermia susceptibility. Circulation 58, 916, 1978.
- Fenoglio, J.J., Irey, N.S.: Myocardial changes in malignant hyperthermia. Am. J. Pathol. 89: 51–56, 1977.
- Mambo, N.C., Silver, M.D., McLaughlin, P.R., Huckell, V.F., McEwan, P.M., Britt, B.A., Morch, J.E.: Malignant hyperthermia susceptibility—A light and electron microscopie study of endomyocardial biopsy specimens from nine patients. Human Pathology 11: 381–388, 1980.
- Britt, B.A.: Malignant hyperthermia. Mod. Med. Can. 31: 511–517, 1976.